Study protocol of an open-label prospective phase II umbrella study of precise neoadjuvant therapy for patients with stage II-IIIB resectable non-small cell lung cancer (PURPOSE)

BACKGROUND: The outcomes of locally advanced non-small cell lung cancer (LA-NSCLC) are unfavorable mainly due to a high risk of cancer recurrence. Only around 5% of patients can benefit from perioperative chemotherapy which is the current standard treatment. Recently, promising results with neoadjuv...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yiyang, Zhai, Haoran, Wang, Jiaming, Mao, Teng, Ji, Chunyu, Bao, Feichao, Gu, Zhitao, Fang, Wentao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9798087/
https://www.ncbi.nlm.nih.gov/pubmed/36591460
http://dx.doi.org/10.3389/fonc.2022.1052774

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9798087/
https://www.ncbi.nlm.nih.gov/pubmed/36591460
http://dx.doi.org/10.3389/fonc.2022.1052774

Ejemplares similares